Galderma is opening its U.S. and Latin America headquarters in Miami, establishing a new operational center for its U.S. business.
Located in Miami’s Brickell district, the headquarters will serve as the primary base for U.S. commercial roles across Dermatological Skincare and selected functional teams. Galderma also plans to host healthcare professionals at the facility, which features a dedicated injection room designed to support hands-on training, educational programs, and the development of educational materials.
The space also includes an installation modeled on the ALASTIN Signature Practice experience, giving visiting professionals a firsthand look at how regenerative, peri-procedural skincare integrates into everyday patient care.
“As our largest market, the United States is central to Galderma’s long-term growth,” Flemming Ørnskov, MD, MPH, Galderma SA as Chief Executive Officer, in a news release. “This investment reflects our confidence in its continued expansion and our ambition to build Galderma into a dermatology powerhouse, scientifically, commercially, and operationally. By bringing key members of our U.S. and Latin America leadership teams together in Miami, we are creating a strategic hub that strengthens collaboration and enables us to execute our Integrated Dermatology Strategy with even greater impact.”
“Our new headquarters reflects how we want to work – bringing together expertise from across the business so teams can collaborate more effectively and move with greater agility,” adds Silvina Nordenstohl, President and Head of the U.S. Region for Galderma. “It strengthens our ability to execute on our strategy while supporting Galderma’s continued growth in the United States.”
